ACACB is a novel metabolism-related biomarker in the prediction of response to cetuximab therapy inmetastatic colorectal cancer.
Hong HJ, Shao Y, Zhang S, Yang G, Jia H, Yang X, Huang L, Li S, Aikemu B, Zhang L, et al. Acta Biochim Biophys Sin (Shanghai). 2022 Sep 25; 54(11):1671-1683.